NEW YORK (GenomeWeb News) – Australian molecular diagnostics developer Genera Biosystems said today that its upcoming initial public offering has closed oversubscribed, with demand for shares outweighing the number of shares offered.
 
The company expects its stock will begin trading on the Australian Stock Exchange under the ticker symbol GBI during the first week of June. Genera said it expects its market capitalization to be around AU $25 million ($24.1 million) when it begins trading.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers report using genotyping to tie together illegal ivory shipments and trace them back to a handful of cartels, the New York Times reports.

Researchers find that historical factors influence which genes are the most highly studied, the Atlantic reports.

The US National Science Foundation's new sexual harassment policy is to go into effect next month, according to Nature News.

In Nature this week: genomic ancestry analysis of Sardinians, current noncoding mutations in colorectal cancer, and more.